the higher likelihood of disease relapse following GCs therapy in patients with IgG4-RD.
by 3 (20%), 0 and 1 (14%) and 4 (8%). Histological confirmation was obtained by transbronchial biopsy (66%), cutaneous (12%) or lymph node biopsy (12%) in 90% of the patients. 90% of patients have been treated with oral glucocorticoids and 42% associate immunosuppressive therapy. The ACE levels showed no statistical association with any of the variables studied, although a very clear association (p=0.04754) was observed between the course of the disease and the presence of extrapulmonary symptoms: from the 25 patients without extrapulmonary symptoms, only in 35% of cases the process become chronic. Conclusions: Our results, in general, coincide with what is published in the literature. In our cohort, initial diagnosis of S was relatively high (28/50 =56%), while misdiagnosis was relatively low (6/50 =12%). The level of ACE does not seem to be clearly associated with the presence of extrapulmonary symptoms, nor with the course of S. However, the presence of extra-pulmonary symptoms seems to lead to a chronification Background: Thymoma is the most common neoplasm originated from the thymus gland and accounting for 50% of anterior mediastinal tumors. Within its clinical manifestations are included the loss of self-tolerance and the development of autoimmunity. Objectives: To study the frequency of autoimmune diseases (AD) in patients with thymoma and to describe their clinical characteristics and outcome. Methods: We performed a retrospective observational study of a cohort of patients diagnosed with thymoma and followed-up in our center between January 1985 and September 2016. The variables evaluated included demographics, thymoma characteristics, clinical and analytical manifestations of autoimmunity, treatment and outcome. Results: A total of 83 patients were included, 56.6% of them women, with a mean age at diagnosis of the thymoma of 58.4±15.8 years (range: 16-94), 31.3% of which corresponded to type I The classification of Masaoka, 39.1% to II, 17.2% to III and 10.9% to IV. There were one or more AD associated in 41 cases (49.4%). The most frequent diagnoses were myasthenia gravis (19), systemic lupus erythematosus (SLE) (4), subacute cutaneous lupus erythematosus (1), Sjögren's syndrome (1), rheumatoid arthritis (1), spondyloarthritis (1), sarcoidosis (1), hemolytic anemia (2), pernicious anemia (1), aplastic anemia (1), cutaneous limited systemic sclerosis (1), urticaria-vasculitis, erythroblastopenia (1), recurrent pericarditis (1), thyroid disease (2) and lichen planus (1). The diagnosis of AD preceded to thymoma in 38.2% of cases and was later in the remaining cases. In 4 cases there was also a concomitant primary immunodeficiency (variable common immunodeficiency 3, CD4 immunodeficiency 1). The most frequently identified autoantibodies were anti-acetylcholine receptor (14/41, 34.1%), anti-striated muscle (3/41, 7.3%), ANA (11/41, 26.8%), (3/41, 7.3%), rheumatoid factor (3/41, 7.3%), anti-thyroid (3/41, 7.3%), antiphospholipids (2/41, 9%) and anticentromere (1/41, 2.4%). In the comparison of patients with and without associated AD, no significant differences were found regarding age, sex or Masaoka classification. There were 6 deaths, 4 in group with associated AD and 2 in the group without AD, but without significant difference (p=0.3797). Conclusions: In the analyzed population of patients with thymoma of our center, almost half of them developed AD, which in a major group preceded the diagnosis of neoplasia. The spectrum of autoimmunity associated with thymoma was quite broad, including organ-specific AD such as myasthenia gravis (which is most frequently described in the literature) and autoimmune cytopenias, but also to systemic AD, the most common being SLE. The autoimmunity study should be included in the assessment of the patient with thymoma as it could contribute to the early diagnosis of associated AD. 1 A 60 year old male presented with a 6 year history of intermittent fever as high as 103.5, lasting 3-4 weeks with associated peritoneal symptoms, arthralgias, myalgias, lymphadenopathy, bilateral episcleritis, erythematous rash in his torso. Prednisone up to 60 mg daily only partially alleviated his symptoms and colchicine was ineffective. Objectives: To explore the role of mosaicism in a patient with adult onset TRAPS phenotype.
